IncFact
Company Profiles: Revenue, Growth, Competition

ALCRESTA THERAPEUTICS Revenue, Growth & Competitor Profile

DBA ALCRESTA, INC.
Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Alcresta Therapeutics

Access the complete profile.

Alcresta Therapeutics Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry3254 Pharmaceutical & Medicine Manufacturing
Address130 Turner St Bldg 3 Ste 200
Waltham, MA 02453

alcresta.com
Note: Revenues for privately held companies are statistical evaluations.


Alcresta Therapeutics's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Pharmaceutical & Medicine Manufacturing industry.


Alcresta Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Alcresta Therapeutics Annual Revenue and Growth Rate

Alcresta Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Alcresta Therapeutics's revenues are gauged from an analysis of company filings.



Investor Activity

Alcresta Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
March 3, 2020 17 50%$20 MM
Complete list of funding rounds and total amounts in the Company Report




Alcresta Therapeutics's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Alcresta Therapeutics Revenue (Sales) Alcresta Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Alcresta Therapeutics is developing and marketing. Alcresta Therapeutics doesn't have any recent trademark applications, indicating Alcresta Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
ALCRESTA PHARMACEUTICALS
Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and would healing, mental illness, pulmonary, muscular and respiratory diseases and disorders
07/20/2015
FULFILLING POTENTIAL
Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and would healing, mental illness, pulmonary, muscular and respiratory diseases and disorders
07/20/2015

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Alcresta Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Alcresta Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Pharmaceutical & Medicine Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Alcresta Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Alcresta Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PFIZERNew York, NY100 
ABBOTT LABORATORIESAbbott Park, IL91 
BRISTOL-MYERS SQUIBBPrinceton, NJ86 
MERCK SHARP & DOHMERahway, NJ66 
ELI LILLYIndianapolis, IN65 
CSL BEHRINGKing Of Prussia, PA64 
CSLB HOLDINGSKing Of Prussia, PA63 
MERCKRahway, NJ62 
ALLERGANChicago, IL61 




Nearby Competitors

These companies are similar in business line and location to Alcresta Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
REPLIGENWaltham, MA100 
APELLIS PHARMACEUTICALSWaltham, MA67 
CUBIST PHARMACEUTICALSLexington, MA59 
BIOVERATIV U.S. LLC.Waltham, MA58 
ABCAMWaltham, MA29 
KARYOPHARM THERAPEUTICSNewton, MA25 




Future Competition: Alcresta Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Alcresta Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Alcresta Therapeutics Competitors